Back
EHRA Premium Access

Eligibility of CRT Patients for Subcutaneous Implantable Cardioverter Defibrillators

Session: Poster session 2 - Subcutaneous ICD
Topic: Implantable Cardioverter / Defibrillator
Event: EHRA 2018

Congress Presentation

Add to my library

Like

9 more presentations in this session

Insight into screening results and post-implantation exercise testing in recipients of a subcutaneous Implantable cardioverter defibrillator

Speaker: Doctor N. Dayal (Geneva, CH)

Access
Abstract
Slides
Like
Thumbnail

Universal S-ICD eligibility: eliminating the need for pre-implant screening using mathematical vector rotation and a gradient filter

Speaker: Doctor B. Wiles (London, GB)

Access
Abstract
Slides
Like
Thumbnail

Subcutaneous implantable cardioverter defibrillator in patients with arrhythmogenic right ventricular cardiomyopathy: a single center italian experience

Speaker: Professor F. Migliore (Padova, IT)

Access
Abstract
Slides
Like
Thumbnail

Optimization of cardiac resynchronization therapy device selection guided by cardiac magnetic resonance imaging is cost-effective

Speaker: Doctor M. Linhart (Barcelona, ES)

Access
Abstract
Like
Thumbnail

Health Care Consumption after ICD/CRT-D replacement: preliminary results from the DECODE registry

Speaker: Doctor E. Menardi (Vignolo, IT)

Access
Abstract
Like
Thumbnail

Access the full session

Poster session 2 - Subcutaneous ICD

Speakers: Doctor N. Dayal, Doctor B. Wiles, Professor F. Migliore, Doctor M. Linhart, Doctor E. Menardi
Access
Like
Thumbnail

About the event

Image

EHRA 2018

18 March - 20 March 2018

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

logo Bristol Myers Squibb Explore sponsored resources
logo Novo Nordisk Explore sponsored resources